Comparing with normal controls, THBS1-IT1 showed significant different expression in BRCA, cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), head and neck squamous cell carcinoma (HNSC), KIRC, kidney chromophobe (KICH), kidney renal papillary cell carcinoma (KIRP), lung squamous cell carcinoma (LUSC), lung adenocarcinoma (LUAD), stomach adenocarcinoma (STAD), rectum adenocarcinoma (READ), thymoma (THYM) and uterine corpus endometrial carcinoma (UCEC) (Figure 6C, P<0.05). Here, THBS1 is linked to rectum adenocarcinoma.